ALB and acute kidney injury: In 2014, the Albumin Italian Outcome Sepsis (ALBIOS) study sought to clarify this and randomly assigned 1818 patients with severe sepsis to either 20% albumin and crystalloid or crystalloid alone, and found no survival benefit at 28 or 90 days, and no difference in AKI [50].